Skip to content
★ Sign in to follow
AS

Amy S. Broidrick

Président/Directeur Scientifique
Qualigen Therapeutics, Inc.
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€25k
▼ Sales (0 ops.)
—

Latest filing published 15 Jun 2022 for Qualigen Therapeutics, Inc., €18k.

Filing timeline

BuySale
Amy S. Broidrick

Insider track record

Disclosed buys
2
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Amy S. Broidrick: trading record in brief

All filings by Amy S. Broidrick on record concern FF EAI Robotics Ecosystem Inc., in the capacity of chief executive. Between 26 April 2021 and 14 June 2022, the trades on record add up to 2 filings.

Purchases make up the whole of the open-market record (2 purchases, €25k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2022, the count stands at 1 purchase and no sales.

The record was last updated on 15 June 2022 with an open-market purchase (€18k) in FF EAI Robotics Ecosystem Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Amy S. Broidrick

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total

1 of 1 declaration